Journal of the National Cancer Institute (JNCI) |
A Plasma Biomarker Panel to Identify Surgically Resectable Early-Stage Pancreatic Cancer |
aoû. 17 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Relevance of Sp Binding Site Polymorphism in WWOX for Treatment Outcome in Pancreatic Cancer |
mai. 16 |
2 ♥ |
Cancers autres (hors CCR et CHC), Pancréas/Voies biliaires |
Journal of the National Cancer Institute (JNCI) |
Risk of Different Cancers Among First-degree Relatives of Pancreatic Cancer Patients: Influence of Probands’ Susceptibility Gene Mutation Status |
mar. 19 |
4 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Design and Validation of the GI-NEC Score to Prognosticate Overall Survival in Patients With High-Grade Gastrointestinal Neuroendocrine Carcinomas |
Jan. 17 |
|
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Colorectal Cancer Incidence Patterns in the United States, 1974–2013 |
aoû. 17 |
3 ♥ |
Cancer colorectal (CCR) |
Journal of the National Cancer Institute (JNCI) |
The Changing Face of Noncardia Gastric Cancer Incidence Among US Non-Hispanic Whites |
juin. 18 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic Cancer |
avr. 17 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial |
nov. 15 |
1 ♥ |
Cancer colorectal (CCR) |
Journal of the National Cancer Institute (JNCI) |
Claudin18.2-Specific Chimeric Antigen Receptor Engineered T Cells for the Treatment of Gastric Cancer |
avr. 19 |
4 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Coffee Consumption and Risk of Gallbladder Cancer in a Prospective Study |
mar. 17 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Prognostic Value of Clinical vs Pathologic Stage in Rectal Cancer Patients Receiving Neoadjuvant Therapy |
mai. 18 |
4 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
The Efficacy and Safety of First-line Chemotherapy in Advanced Esophagogastric Cancer: A Network Meta-analysis |
aoû. 16 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Overall Survival Prediction and Usefulness of Second-Line Chemotherapy in Advanced Pancreatic Adenocarcinoma |
oct. 17 |
3 ♥ |
Carcinome hépatocellaire (CHC) |
Journal of the National Cancer Institute (JNCI) |
Personalizing Survival Predictions in Advanced Colorectal Cancer: The ARCAD Nomogram Project |
juin. 18 |
2 ♥ |
Cancer colorectal (CCR) |
Journal of the National Cancer Institute (JNCI) |
Sweetened Beverage Consumption and Risk of Biliary Tract and Gallbladder Cancer in a Prospective Study |
juin. 16 |
2 ♥ |
Cancers autres |
Journal of the National Cancer Institute (JNCI) |
Limited Use of Adjuvant Therapy in Patients With Resected Gallbladder Cancer Despite a Strong Association With Survival. |
juil. 17 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Aspirin and Risk of Gastric Cancer After Helicobacter pylori Eradication: A Territory-Wide Study |
juil. 18 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Tumor Regression Grading After Preoperative Chemoradiotherapy as a Prognostic Factor and Individual-Level Surrogate for Disease-Free Survival in Rectal Cancer. |
déc. 17 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Low-fat Dietary Pattern and Pancreatic Cancer Risk in the Women's Health Initiative Dietary Modification Randomized Controlled Trial |
Jan. 18 |
1 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Changing Landscape of Liver Cancer in California: A Glimpse Into the Future of Liver Cancer in the United States |
déc. 18 |
1 ♥ |
Carcinome hépatocellulaire (CHC) |
Journal of the National Cancer Institute (JNCI) |
Risk of Advanced Neoplasia Using the National Cancer Institute’s Colorectal Cancer Risk Assessment Tool |
aoû. 16 |
2 ♥ |
Cancer colorectal (CCR) |
Journal of the National Cancer Institute (JNCI) |
Incidence of Diabetes in Colorectal Cancer Survivors |
juin. 16 |
2 ♥ |
Cancer colorectal (CCR) |
Journal of the National Cancer Institute (JNCI) |
The Balance Between Cytotoxic T-cell Lymphocytes and Immune Checkpoint Expression in the Prognosis of Colon Tumors |
Jan. 18 |
1 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Analysis of Postoperative Recurrence in Stage I–III Midgut Neuroendocrine Tumors |
mar. 18 |
1 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial. |
sep. 17 |
2 ♥ |
Cancers autres (hors CCR et CHC) |